The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation

被引:0
作者
Swarna L. Vijayaraj
Rebecca Feltham
Maryam Rashidi
Daniel Frank
Zhengyang Liu
Daniel S. Simpson
Gregor Ebert
Angelina Vince
Marco J. Herold
Andrew Kueh
Jaclyn S. Pearson
Laura F. Dagley
James M. Murphy
Andrew I. Webb
Kate E. Lawlor
James E. Vince
机构
[1] The Walter and Eliza Hall Institute of Medical Research,Department of Medical Biology
[2] University of Melbourne,Centre for Innate Immunity and Infectious Diseases
[3] Hudson Institute of Medical Research,Department of Microbiology
[4] Monash University,Department of Molecular and Translational Science
[5] Monash University,undefined
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin-1β (IL-1β) is activated by inflammasome-associated caspase-1 in rare autoinflammatory conditions and in a variety of other inflammatory diseases. Therefore, IL-1β activity must be fine-tuned to enable anti-microbial responses whilst limiting collateral damage. Here, we show that precursor IL-1β is rapidly turned over by the proteasome and this correlates with its decoration by K11-linked, K63-linked and K48-linked ubiquitin chains. The ubiquitylation of IL-1β is not just a degradation signal triggered by inflammasome priming and activating stimuli, but also limits IL-1β cleavage by caspase-1. IL-1β K133 is modified by ubiquitin and forms a salt bridge with IL-1β D129. Loss of IL-1β K133 ubiquitylation, or disruption of the K133:D129 electrostatic interaction, stabilizes IL-1β. Accordingly, Il1bK133R/K133R mice have increased levels of precursor IL-1β upon inflammasome priming and increased production of bioactive IL-1β, both in vitro and in response to LPS injection. These findings identify mechanisms that can limit IL-1β activity and safeguard against damaging inflammation.
引用
收藏
相关论文
共 114 条
  • [1] Menu P(2011)The NLRP3 inflammasome in health and disease: the good, the bad and the ugly Clin. Exp. Immunol. 166 1-15
  • [2] Vince JE(2012)Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nat. Rev. Drug Discov. 11 633-652
  • [3] Dinarello CA(2019)Inflammasomes in neuroinflammatory and neurodegenerative diseases EMBO Mol. Med. 11 e10248-1710
  • [4] Simon A(2016)Inhibiting the inflammasome: a chemical perspective J. Med. Chem. 59 1691-832
  • [5] van der Meer JW(2010)The inflammasomes Cell 140 821-420
  • [6] Voet S(2016)Inflammasomes: mechanism of assembly, regulation and signalling Nat. Rev. Immunol. 16 407-840
  • [7] Srinivasan S(2018)Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity J. Exp. Med. 215 827-399
  • [8] Lamkanfi M(2019)Stressing out the Mitochondria: mechanistic insights into NLRP3 inflammasome activation J. Leukoc. Biol. 105 377-665
  • [9] van Loo G(2015)Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death Nature 526 660-671
  • [10] Baldwin AG(2015)Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling Nature 526 666-1298